Dabur India Ltd. News and Updates

Name: Latest research reports of Dabur India Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Dabur India Ltd.
Rating: 5
Author: Geojit BNP Paribas

Keep track of all breaking news on Dabur India Ltd. from all sources in a single place.

Load latest

Dabur India Ltd.

09 Nov 2020

538.85

-0.96%

Accumulate Dabur India; target of Rs 589: Arihant Capital

Moneycontrol

Arihant Capital recommended accumulate rating on Dabur India with a target price of Rs 589 in its research report dated November 05, 2020.

Dabur India Ltd. has an average target of 563.57 from 7 brokers.

Dabur India Ltd.

09 Nov 2020

538.85

-0.96%

DABUR INDIA LTD

Buy: Dabur India Ltd.

Recommendation Target

Geojit BNP Paribas

Dabur India Ltd (Dabur), a leading Indian FMCG company, is a world leader in Ayurveda with a portfolio of over 250 Herbal/Ayurvedic products. The company operates through Health Supplements, Digestives, Shampoos, Hair...

Dabur India Ltd. is trading above all available SMAs

Dabur India Ltd.

07 Nov 2020

538.85

-0.96%

Reduce Dabur India; target of Rs 520: Dolat Capital Market

Moneycontrol

Dolat Capital Market recommended Reduce rating on Dabur India with a target price of Rs 520 in its research report dated November 03, 2020.

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

07 Nov 2020

538.85

-0.96%

Dabur India

Sell: Dabur India Ltd.

Target

Dolat Capital

We have upward revised our FY21E and FY23E EPS estimates at Rs 9.5 (+13%) and Rs 9.8 (+0.8%) and introduced FY23E EPS estimates at Rs10.8. We value the stock at 48x FY23E EPS to arrive at a TP of Rs 520....

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

06 Nov 2020

538.85

-0.96%

Buy Dabur; target of Rs 605: Motilal Oswal

Moneycontrol

Motilal Oswal is bullish on Dabur recommended buy rating on the stock with a target price of Rs 605 in its research report dated November 03, 2020.

Dabur India Ltd. has an average target of 563.57 from 7 brokers.

Dabur India Ltd.

05 Nov 2020

538.85

-0.96%

Dabur India

Accumulate: Dabur India Ltd.

Target

Arihant Capital

Dabur India Limited ( Dabur) earnings surprised the market with double digit volume growth in in Q2FY21 . Dabur's domestic business grew 16.8% YoY, much higher than the anticipated mid-single digit growth. Profit for the quarter grew by 19.9%YoY/+41.6% QoQ to Rs 483 Cr above our estimates of Rs 384 cr on the back of growth in topline, higher other Income and lower finance cost during Q2FY21. Consolidated revenue stood at Rs 2516 cr , above our estimates Rs2,274 cr registering a growth of 13.7%YoY/+27.1%QoQ mainly led by healthy growth in...

Axis Direct increased Hold price target of Dabur India Ltd. to 630.0 on 05 Sep, 2025.

Dabur India Ltd.

04 Nov 2020

538.85

-0.96%

Dabur India nears 52-week high on strong volume growth in September qtr

Business Standard

The stock has rallied 5% in two trading days, quoting close to its 52-week high level of Rs 535 touched on October 6, 2020

Axis Direct increased Hold price target of Dabur India Ltd. to 630.0 on 05 Sep, 2025.

Dabur India shares price up on good Q2 numbers; CLSA retains 'buy'

Moneycontrol | 04 Nov 2020 3 more

Dabur India Ltd.

04 Nov 2020

538.85

-0.96%

Dabur India: Q2FY21 Result Review

Accumulate: Dabur India Ltd.

IDBI Capital

DABUR India (DABUR) 2QFY21 result was above our estimates. Consolidated revenue growth recovered to high double digit after two consecutive quarter of decline. Health supplement portfolio delivered astronomical 71%YoY revenue growth driven by 2x sales of Chyawanprash. In HPC; oral care, hygiene and shampoo portfolio revenue grew at 18-38% rate while revenue from Odomos, Odonil and Hair Oil portfolio declined 6-10%. Food continues to face growth head-winds due to sub-par performance of beverage portfolio. Performance of international business remained satisfactory. We expect DABUR, as a category leader in India, to benefit from the penetration of...

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

04 Nov 2020

538.85

-0.96%

Result Update:Dabur India

Buy: Dabur India Ltd.

Axis Direct

We have marginally revised our estimates for FY21/22/23E for double digit volume growth and strategic shift in A&P; spends. Retain BUY with unchanged TP of Rs.610 as we value the stock at 50x its FY23E EPS.

Axis Direct increased Hold price target of Dabur India Ltd. to 630.0 on 05 Sep, 2025.

Dabur India Ltd.

04 Nov 2020

538.85

-0.96%

Dabur India

Buy: Dabur India Ltd.

Target

ICICI Securities Limited

During the quarter, sales of health supplements, OTC, ethical saw 70.8%, 56.1% & 26.4% growth, respectively. Further, oral care & shampoo also witnessed 24.2% & 17.8% growth, respectively. The company continues to strengthen its market share in Chyawanprash (190 bps increase), toothpaste (90 bps increase) and shampoo (80 bps increase). We believe growth in health & immunity products is far more structural compared to hygiene or instant food products. The penetration levels of Chyawanprash & honey is ~4% & ~25%, respectively, which poses immense growth opportunity in...

Dabur India Ltd. is trading above all available SMAs

Is Dabur India Ltd. worth buying?

670 Votes:

Buy 76.72%

Sell 12.09%

Hold 11.19%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf